New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
about
Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma.Disseminated histoplasmosis presenting as thrombotic microangiopathy.Thrombotic microangiopathies: an update.Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells.
P2860
New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
New aspects in the pathogenesi ...... and hemolytic uremic syndrome.
@ast
New aspects in the pathogenesi ...... and hemolytic uremic syndrome.
@en
New aspects in the pathogenesi ...... and hemolytic uremic syndrome.
@nl
type
label
New aspects in the pathogenesi ...... and hemolytic uremic syndrome.
@ast
New aspects in the pathogenesi ...... and hemolytic uremic syndrome.
@en
New aspects in the pathogenesi ...... and hemolytic uremic syndrome.
@nl
prefLabel
New aspects in the pathogenesi ...... and hemolytic uremic syndrome.
@ast
New aspects in the pathogenesi ...... and hemolytic uremic syndrome.
@en
New aspects in the pathogenesi ...... and hemolytic uremic syndrome.
@nl
P2860
P1476
New aspects in the pathogenesi ...... and hemolytic uremic syndrome.
@en
P2093
P2860
P304
236-61; discussion 311-2
P356
10.1046/J.1468-0734.2001.00044.X
P577
2001-09-01T00:00:00Z